Table 3.
Characterization of the deactivation mechanism (%) for the paths shown in Fig. 3
| Ade* | A1a | A2a | |||
| Yield (%) | 100 (80) | 0 (20) | |||
| Time (ps) | 0.63 | — | |||
| Gua | G1a | ||||
| Yield (%) | 100 | ||||
| Time (ps) | 0.28 | ||||
| Thy† | P1a | P1b | P1c | P1d | P2a |
| Yield (%) | 100 | NA | NA | NA | 0 |
| Time (ps) | 2.3 | NA | NA | NA | — |
| Ura† | P1a | P1b | P1c | P1d | P2a |
| Yield (%) | 60 | NA | NA | NA | 31 |
| Time (ps) | 1.5 | NA | NA | NA | 0.65 |
| Cyt | C1a | C1b | C1c | C1d | C2 |
| Yield (%) | 87 | 58 | 16 | 12 | 13 |
| Time (ps) | 0.01 | 0.5 | — | 0.5 | 0.01 |
NA, not available.
*Energy window C. (Values for 4-aminopyrimidine are given in parenthesis.)
†High-energy window.